LLYEli Lilly & Co

Median target
$1,367
calls from the last 12 months
Implied return
+18.6%
median target vs. price
Coverage
29 analysts · 35 calls
updated in the last 12 months
Consensus
25/3/1+24 net
Buy / Hold / Sell

Which analysts are behind LLY's consensus?

See every current rating, price target and the analysts' track records for Eli Lilly & Co — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 29 analysts with calls on LLY updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

LLY elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: #27 in Losing attention (0.7× vs usual)

DateSourceWhoActionDetailAmount
2026-08-17InsidersJonsson PatrikEVP & President, LLY IntInsider sale6.5K sh @ $1175.10 · planned trade$7.6M
2026-08-10InsidersZakrowski Donald ASVP, Finance, & CAOInsider sale2.0K sh @ $1185.01 · planned trade$2.4M
2026-08-07InsidersHakim AnatEVP, GC & SecretaryInsider sale5.0K sh @ $1190.00 · planned trade$6.0M
2026-07-10CongressDan NewhouseWA-WA04Salesince trade -3.0%, vs market +3.9%$1K–$15K
2026-07-01CongressMichael RulliOH-OH06Salesince trade -3.3%, vs market +5.4%$1K–$15K
2026-06-10ExecutiveMullin, MarkwayneSecretarySaleLily Eli & Co Com (LLY)$100,001 - $250,000
2026-04-08CongressElizabeth FletcherTX-TX07Salesince trade +21.1%, vs market -8.5%$1K–$15K
2026-04-02CongressByron DonaldsFL-FL19Purchasesince trade +23.4%, vs market +7.3%$1K–$15K
2026-04-02CongressByron DonaldsFL-FL19Purchasesince trade +23.4%, vs market +7.3%$1K–$15K
2026-03-13CongressGilbert CisnerosCA-CA39Salesince trade +17.2%, vs market -1.9%$1K–$15K

More: congressional trades on LLY · insider activity · executive branch · trending